Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London
· Delayed Price · Currency is GBP · Price in USD 572.51
+33.37 (6.19%)
At close: May 12, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 46.04 billion as of May 13, 2025. Its market cap has decreased by -40.13% in one year.
Market Cap
46.04B
Enterprise Value
34.75B
Revenue
10.90B
Ranking
n/a
PE Ratio
13.22
Stock Price
572.51
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 46.04B, an increase of 47,801.86%. That is a compound annual growth rate of 20.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.79B |
| GSK plc | 55.98B |
| Haleon | 36.67B |
| Smith & Nephew | 9.35B |
| ConvaTec Group | 5.26B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.39B |